Author:
Sas David J.,Harris Peter C.,Milliner Dawn S.
Publisher
Springer Science and Business Media LLC
Reference74 articles.
1. CJ D (2001) Primary hyperoxaluria. In: Scriver CRBA, Sly WS, Valle D, Childs B, Kinzler KW, Vogelstein B (ed) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 3323–3367
2. Archer HE, Dormer AE, Scowen EF, Watts RW (1957) Primary hyperoxaluria. Lancet 273(6990):320–322
3. Purdue PE, Takada Y, Danpure CJ (1990) Identification of mutations associated with peroxisome-to-mitochondrion mistargeting of alanine/glyoxylate aminotransferase in primary hyperoxaluria type 1. J Cell Biol 111(6 Pt 1):2341–2351
4. Li X, Knight J, Fargue S, Buchalski B, Guan Z, Inscho EW, Liebow A, Fitzgerald K, Querbes W, Todd Lowther W, Holmes RP (2016) Metabolism of (13)C5-hydroxyproline in mouse models of primary hyperoxaluria and its inhibition by RNAi therapeutics targeting liver glycolate oxidase and hydroxyproline dehydrogenase. Biochim Biophys Acta 1862(2):233–239.
https://doi.org/10.1016/j.bbadis.2015.12.001
5. Cramer SD, Ferree PM, Lin K, Milliner DS, Holmes RP (1999) The gene encoding hydroxypyruvate reductase (GRHPR) is mutated in patients with primary hyperoxaluria type II. Hum Mol Genet 8(11):2063–2069
Cited by
44 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献